Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
#4204 Novo Nordisk Tokenized Stock (Reality)
≈ $ 261.0 ths.
Issued supply: 6 906.77 tokens.
FDV / market cap: 1.00×.
A value below 1 can reflect different timestamps or methods in the underlying data.
Supply: CoinGecko · 2026-11-20 22:15:57 UTC.
Quote: 2026-11-21 23:31:15 UTC.
Calculated using the last available price; quote freshness is unconfirmed.
Price: low and high
How the range is calculated
24h uses saved quotes from the last 24 hours. The 30-day and one-year views use daily lows and highs for UTC calendar days, including today. Gaps are not filled; prices may have differed between samples. The dot marks the current price, not a buy signal.
All time uses CoinGecko’s USD ATL and ATH. Other currencies use the current exchange rate; these are not historical records in the selected currency.
RNVO security & risks
Other checks (4) Detected: 1
- Proxy contract
- Detected
- Blacklist
- No data
- Whitelist
- No data
- Balance changes
- No data
Exchanges where RNVO is traded
No dataCalculator RNVO
1 RNVO = 37.79 USD
What is Novo Nordisk Tokenized Stock (Reality)?
Official websites and links for Novo Nordisk Tokenized Stock (Reality)
There are currently about 3 official links to Novo Nordisk Tokenized Stock (Reality) websites and social media:
- Website - realityfinance.xyz
- Twitter - twitter.com/RealityFi_xyz
- Facebook - facebook.com